# Miltenyi Biotec (Germany)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/miltenyi-biotec-germany/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 26 |
| Citations | 159,222 |
| City | Cologne |
| Country | DE |
| Description | Miltenyi Biotec (Germany) is a research organisation in Cologne, DE. OpenAlex records 1,259 works and 159,222 citations for it. 835 researchers list it as their most recent affiliation. |
| Homepage | http://www.miltenyibiotec.com/en/ |
| OpenAlex ID | https://openalex.org/I137469784 |
| Researchers | 835 |
| ROR ID | https://ror.org/00qhe6a56 |
| Type | company |
| Wikidata ID | https://www.wikidata.org/wiki/Q1671300 |
| Works | 1,259 |

## University papers

- [Understanding the global measurement of willingness to pay in health](https://scholariq.org/papers/understanding-the-global-measurement-of-willingness-to-pay-in-health/)
- [Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan](https://scholariq.org/papers/persistence-with-biologic-agents-for-the-treatment-of-rheumatoid-arthritis-in/)
- [Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database](https://scholariq.org/papers/persistence-rates-and-medical-costs-of-biological-therapies-for-psoriasis/)
- [Estimating Prevalence and Healthcare Utilization for Treatment-Resistant Depression in Japan: A Retrospective Claims Database Study](https://scholariq.org/papers/estimating-prevalence-and-healthcare-utilization-for-treatment-resistant/)
- [Cultural beliefs, utility values, and health technology assessment](https://scholariq.org/papers/cultural-beliefs-utility-values-and-health-technology-assessment/)
- [Economic burden of osteoporotic fractures in Austria](https://scholariq.org/papers/economic-burden-of-osteoporotic-fractures-in-austria/)
- [Patient preferences for HIV/AIDS therapy - a discrete choice experiment](https://scholariq.org/papers/patient-preferences-for-hiv-aids-therapy-a-discrete-choice-experiment/)
- [The Determinants of Pharmaceutical R&amp;D Expenditures: Evidence from Japan](https://scholariq.org/papers/the-determinants-of-pharmaceutical-r-and-amp-d-expenditures-evidence-from-japan/)
- [Pharmaceutical regulation in Europe and its impact on corporate R&amp;D](https://scholariq.org/papers/pharmaceutical-regulation-in-europe-and-its-impact-on-corporate-r-and-amp-d/)
- [Shared Decision-Making in Patients With Prostate Cancer in Japan: Patient Preferences Versus Physician Perceptions](https://scholariq.org/papers/shared-decision-making-in-patients-with-prostate-cancer-in-japan-patient/)
- [Treatment patterns and medical cost of systemic lupus erythematosus patients in Japan: a retrospective claims database study](https://scholariq.org/papers/treatment-patterns-and-medical-cost-of-systemic-lupus-erythematosus-patients-in/)

## University researchers

- [Jörg Mahlich](https://scholariq.org/researchers/jorg-mahlich/)

## University top topics

Showing 8 of 25.

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Viral Infectious Diseases and Gene Expression in Insects](https://scholariq.org/topics/viral-infectious-diseases-and-gene-expression-in-insects/)
- [Virus-based gene therapy research](https://scholariq.org/topics/virus-based-gene-therapy-research/)
- [Single-cell and spatial transcriptomics](https://scholariq.org/topics/single-cell-and-spatial-transcriptomics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
